Chester County News and Community Website
WILMINGTON, DE — Acorn Energy, Inc. (OTCQB: ACFN) announced robust financial results for the third quarter of 2024, emphasizing the impact of a significant contract with a leading cell phone …
Acorn Energy Sees Strong Q3 Performance Amid New Contracts Read More
CHESTERBROOK, PA — Trevena, Inc. (Nasdaq: TRVN) released its financial results for the third quarter ending September 30, 2024, revealing significant corporate changes as the company navigates ongoing financial challenges. …
Trevena, Inc. Navigates Financial Challenges and Strategic Changes Read More
WILMINGTON, DE — Ashland Inc. (NYSE: ASH) has reported its financial results for the fourth quarter of fiscal year 2024, ending September 30. The company revealed a sales increase to $522 …
Ashland Inc. Reports Strong Fourth Quarter and Outlines Future Plans Read More
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX), a clinical-stage biopharmaceutical company, has reported its financial results for the third quarter ending September 30, 2024, alongside significant corporate milestones. The …
Context Therapeutics Announces Q3 2024 Financial Results and Strategic Advances Read More
WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD), a precision oncology company, has shared its third-quarter 2024 financial results alongside significant updates on its clinical pipeline. The company continues to …
Prelude Therapeutics Reports Q3 2024 Results and Clinical Progress Read More
MALVERN, PA — Vishay Intertechnology, Inc. (NYSE: VSH) released its financial results for the third quarter of 2024, reporting steady revenues amidst ongoing industry challenges. The company posted revenues of …
Vishay Intertechnology Reports Stable Revenue Amid Inventory Challenges in Q3 2024 Read More
WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) has released its third-quarter 2024 financial results, showcasing significant progress in its clinical trials and a stable financial position. The company is …
Arbutus Biopharma Advances Clinical Trials and Strengthens Financial Position in Q3 2024 Read More
KING OF PRUSSIA, PA — Vertex, Inc. (NASDAQ: VERX) has announced robust financial results for the third quarter of 2024, highlighting significant revenue growth and strategic advancements. The company reported …
Vertex, Inc. Reports Strong Q3 2024 Performance with Strategic Acquisition Boost Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has announced its financial results for the third quarter of 2024, alongside significant corporate updates. The company marked a pivotal milestone with …
Aclaris Therapeutics Highlights Key Advances and Financial Results for Q3 2024 Read More
WILMINGTON, DE — Enovis™ Corporation (NYSE: ENOV) has released its financial results for the third quarter of 2024, showcasing a robust performance driven by significant sales growth and strategic integration efforts. …
Enovis Corporation Reports Strong Q3 2024 Results, Eyes Continued Growth Read More